RMP
OFIX icon

Richards, Merrill & Peterson’s Orthofix Medical OFIX Stock Holding History

Richards, Merrill & Peterson’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-832
Closed -$13.6K – 387
2025
Q1 		$13.6K Hold
832
– – 0.01% 374
2024
Q4 		$14.5K Buy
+832
New +$14.5K 0.01% 355

Other funds holding OFIX

ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACA
AYAL Capital Advisors Toronto, Ontario, Canada $370M AUM 52.93% 1-Year Est. Return

Richards, Merrill & Peterson's OFIX Position: Q2 2025 in Review

Richards, Merrill & Peterson sold out of Orthofix Medical (OFIX) in Q2 2025, closing a stake of 832 shares — an estimated $13.6K sold.

Richards, Merrill & Peterson first reported a position in OFIX in Q4 2024 and held it in 2 quarters. The position peaked at $14.5K in Q4 2024. 158 funds tracked by Wall St. Rank hold OFIX as of Q2 2025.

  • Richards, Merrill & Peterson reported no remaining Orthofix Medical position as of Q2 2025 after selling out during the quarter.
  • Richards, Merrill & Peterson sold 832 Orthofix Medical shares in Q2 2025, an estimated $13.6K.
  • Richards, Merrill & Peterson first reported a position in Orthofix Medical in Q4 2024 and held it in 2 quarters.
  • Richards, Merrill & Peterson's Orthofix Medical position peaked at $14.5K in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2025.

Based on Richards, Merrill & Peterson's 13F filing for Q2 2025, filed 31 Jul 2025.